Cardiovascular Disease (CVD) Completed Phase 3 Trials for Liraglutide (DB06655)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02043054Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)Treatment